Geopolitical tariff and supply chain uncertainties
Ongoing geopolitical conflicts and tariff uncertainties could disrupt supply chains and increase logistics and energy costs.
medium · management_commentaryAlivus Life Sciences Limited — Q4 FY26
Alivus Life Sciences delivered a strong Q4 FY26 with revenue of 689 crore (+6.1% YoY) and EBITDA margin of 34.4% (+230 bps YoY), driven by favorable product mix, cost discipline...
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Raw material cost inflation from war
Solvent costs have increased significantly due to the war, though management expects to pass on costs to customers.
medium · analyst_questionFire incident at H plant impact
A fire at the H plant impacted intermediate production, resulting in a 20 crore loss booked in other expenses, with minor spillover expected in Q1.
low · analyst_questionPotential delays in CDMO deal closures
Management moderated timing for two CDMO deals to early H2 FY27, indicating possible delays from earlier expectations.
low · analyst_question